248 related articles for article (PubMed ID: 15739896)
21. Development of trans-2-[1H-imidazol-4-yl] cyclopropane derivatives as new high-affinity histamine H3 receptor ligands.
Tedford CE; Phillips JG; Gregory R; Pawlowski GP; Fadnis L; Khan MA; Ali SM; Handley MK; Yates SL
J Pharmacol Exp Ther; 1999 May; 289(2):1160-8. PubMed ID: 10215700
[TBL] [Abstract][Full Text] [Related]
22. Development of chiral N-alkylcarbamates as new leads for potent and selective H3-receptor antagonists: synthesis, capillary electrophoresis, and in vitro and oral in vivo activity.
Sasse A; Kiec-Kononowicz K; Stark H; Motyl M; Reidemeister S; Ganellin CR; Ligneau X; Schwartz JC; Schunack W
J Med Chem; 1999 Feb; 42(4):593-600. PubMed ID: 10052966
[TBL] [Abstract][Full Text] [Related]
23. Piperidine-containing histamine H3 receptor antagonists of the carbamate series: the alkyl derivatives.
Lazewska D; Kieć-Kononowicz K; Elz S; Pertz HH; Stark H; Schunack W
Pharmazie; 2005 Jun; 60(6):403-10. PubMed ID: 15997826
[TBL] [Abstract][Full Text] [Related]
24. Ciproxifan and chemically related compounds are highly potent and selective histamine H3-receptor antagonists.
Kathmann M; Schlicker E; Marr I; Werthwein S; Stark H; Schunack W
Naunyn Schmiedebergs Arch Pharmacol; 1998 Dec; 358(6):623-7. PubMed ID: 9879720
[TBL] [Abstract][Full Text] [Related]
25. Importance of the lipophilic group in carbamates having histamine H3-receptor antagonist activity.
Kieć-Kononowicz K; Wiecek M; Sasse A; Ligneau X; Elz S; Ganellin CR; Schwartz JC; Stark H; Schunack W
Pharmazie; 2000 May; 55(5):349-55. PubMed ID: 11828613
[TBL] [Abstract][Full Text] [Related]
26. Potential utility of histamine H3 receptor antagonist pharmacophore in antipsychotics.
von Coburg Y; Kottke T; Weizel L; Ligneau X; Stark H
Bioorg Med Chem Lett; 2009 Jan; 19(2):538-42. PubMed ID: 19091563
[TBL] [Abstract][Full Text] [Related]
27. Progress in the proxifan class: heterocyclic congeners as novel potent and selective histamine H(3)-receptor antagonists.
Grassmann S; Sadek B; Ligneau X; Elz S; Ganellin CR; Arrang JM; Schwartz JC; Stark H; Schunack W
Eur J Pharm Sci; 2002 May; 15(4):367-78. PubMed ID: 11988398
[TBL] [Abstract][Full Text] [Related]
28. Novel qualitative structure-activity relationships for the antinociceptive actions of H2 antagonists, H3 antagonists and derivatives.
Hough LB; Nalwalk JW; Li BY; Leurs R; Menge WM; Timmerman H; Carlile ME; Cioffi C; Wentland M
J Pharmacol Exp Ther; 1997 Dec; 283(3):1534-43. PubMed ID: 9400031
[TBL] [Abstract][Full Text] [Related]
29. Validation of a histamine H3 receptor model through structure-activity relationships for classical H3 antagonists.
Lorenzi S; Mor M; Bordi F; Rivara S; Rivara M; Morini G; Bertoni S; Ballabeni V; Barocelli E; Plazzi PV
Bioorg Med Chem; 2005 Oct; 13(19):5647-57. PubMed ID: 16085419
[TBL] [Abstract][Full Text] [Related]
30. Benzophenone derivatives and related compounds as potent histamine H3-receptor antagonists and potential PET/SPECT ligands.
Sasse A; Ligneau X; Sadek B; Elz S; Pertz HH; Ganellin CR; Arrang JM; Schwartz JC; Schunack W; Stark H
Arch Pharm (Weinheim); 2001 Feb; 334(2):45-52. PubMed ID: 11268774
[TBL] [Abstract][Full Text] [Related]
31. Substituted N-phenylcarbamates as histamine H3 receptor antagonists with improved in vivo potency.
Reidemeister S; Stark H; Ligneau X; Ganellin CR; Schwartz JC; Schunack W
Pharmazie; 2000 Feb; 55(2):83-6. PubMed ID: 10723763
[TBL] [Abstract][Full Text] [Related]
32. Meta-substituted aryl(thio)ethers as potent partial agonists (or antagonists) for the histamine H3 receptor lacking a nitrogen atom in the side chain.
Pelloux-Léon N; Fkyerat A; Piripitsi A; Tertiuk W; Schunack W; Stark H; Garbarg M; Ligneau X; Arrang JM; Schwartz JC; Ganellin CR
J Med Chem; 2004 Jun; 47(12):3264-74. PubMed ID: 15163206
[TBL] [Abstract][Full Text] [Related]
33. 4-(omega-(alkyloxy)alkyl)-1H-imidazole derivatives as histamine H(3) receptor antagonists/agonists.
Meier G; Krause M; Hüls A; Ligneau X; Pertz HH; Arrang JM; Ganellin CR; Schwartz JC; Schunack W; Stark H
J Med Chem; 2004 May; 47(10):2678-87. PubMed ID: 15115409
[TBL] [Abstract][Full Text] [Related]
34. [125I]iodoproxyfan and related compounds: a reversible radioligand and novel classes of antagonists with high affinity and selectivity for the histamine H3 receptor.
Stark H; Purand K; Hüls A; Ligneau X; Garbarg M; Schwartz JC; Schunack W
J Med Chem; 1996 Mar; 39(6):1220-6. PubMed ID: 8632428
[TBL] [Abstract][Full Text] [Related]
35. Novel histamine H3-receptor antagonists with benzyl ether structure or related moieties: synthesis and structure-activity relationships.
Hüls A; Purand K; Stark H; Reidemeister S; Ligneau X; Arrang JM; Schwartz JC; Schunack W
Arch Pharm (Weinheim); 1996; 329(8-9):379-85. PubMed ID: 8915097
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and structure-activity relationships for biphenyl H3 receptor antagonists with moderate anti-cholinesterase activity.
Morini G; Comini M; Rivara M; Rivara S; Bordi F; Plazzi PV; Flammini L; Saccani F; Bertoni S; Ballabeni V; Barocelli E; Mor M
Bioorg Med Chem; 2008 Dec; 16(23):9911-24. PubMed ID: 18976927
[TBL] [Abstract][Full Text] [Related]
37. Search for novel leads for histamine H3-receptor antagonists: amine derivatives.
Stark H; Ligneau X; Lipp R; Arrang JM; Schwartz JC; Schunack W
Pharmazie; 1997 Jun; 52(6):419-23. PubMed ID: 9260265
[TBL] [Abstract][Full Text] [Related]
38. 4-[(1H-imidazol-4-yl) methyl] benzamidines and benzylamidines: novel antagonists of the histamine H3 receptor.
Aslanian R; Brown JE; Shih NY; wa Mutahi M; Green MJ; She S; Del Prado M; West R; Hey J
Bioorg Med Chem Lett; 1998 Aug; 8(16):2263-8. PubMed ID: 9873525
[TBL] [Abstract][Full Text] [Related]
39. 1-alkyl-4-acylpiperazines as a new class of imidazole-free histamine H(3) receptor antagonists.
Zaragoza F; Stephensen H; Knudsen SM; Pridal L; Wulff BS; Rimvall K
J Med Chem; 2004 May; 47(11):2833-8. PubMed ID: 15139761
[TBL] [Abstract][Full Text] [Related]
40. Discovery of histamine H3 receptor antagonistic property of simple imidazole-free derivatives: Preliminary pharmacological investigation.
Barocelli E; Ballabeni V; Manenti V; Flammini L; Bertoni S; Morini G; Comini M; Impicciatore M
Pharmacol Res; 2006 Mar; 53(3):226-32. PubMed ID: 16364652
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
